Cause-group shares of total disability-adjusted life years; percent, 2024.
Australia’s total disease burden is divided among six cause-group segments for 2024. Shares use total disability-adjusted life years as the denominator, with five named groups and a residual for all others. Cancer is the largest named group at 16.4%, followed by mental health and substance use disorders at 14.8%. The five named groups account for 64.1% of total burden, while the residual reflects rounding in the published shares.
| Rank | Entry | Value | Period |
|---|---|---|---|
| 1 | Cancer | 16.4% | 2024 |
| 2 | Mental health and substance use disorders | 14.8% | 2024 |
| 3 | Musculoskeletal conditions | 12.7% | 2024 |
| 4 | Cardiovascular diseases | 11.8% | 2024 |
| 5 | Neurological conditions | 8.4% | 2024 |
| 6 | All other disease groups | 35.9% | 2024 |
Source 1: Australian Burden of Disease Study 2024
Publisher: Australian Institute of Health and Welfare
Dataset/table: Disease burden by cause group
Units: percent of total DALYs
Date checked: 2026-07-15
Evidence: Supports the five named 2024 cause-group shares and total-DALY definition used to form the composition.
DALYs combine fatal and non-fatal health loss. The 2024 study is modelled, and the residual inherits rounding from the published shares.
The five leading cause-group shares were taken from the AIHW 2024 burden results. The all-other segment is 100% minus the five rounded published shares.
Every segment uses one AIHW study, one 2024 total-DALY denominator and one percentage unit.
Keep the visible MarketStats attribution, source line and canonical page link intact. For clean unbranded assets, commercial use or higher-volume reuse, choose one of the licensing tiers below.
This specific graphic needs a source-rights review before an unbranded download. Branded use remains available.
* Free branded use is subject to the Terms and requires attribution/canonical-link preservation. MarketStats licenses the graphic presentation and MarketStats-created editorial layer, not the underlying third-party source data. Source attribution and source-provider obligations still apply.
